Navigation Links
FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data
Date:3/17/2008

Eventually, these problems may cause life-threatening complications, such as overwhelming infections and fatal bleeding. More information about CLL can be accessed at the website for the Lymphoma Research Foundation at: http://www.lymphoma.org.

About Genasense

Genasense inhibits production of Bcl-2, a protein made by cancer cells that is thought to block chemotherapy-induced apoptosis (programmed cell death). By reducing the amount of Bcl-2 in cancer cells, Genasense may enhance the effectiveness of current anticancer treatment. Genta is pursuing a broad clinical development program with Genasense evaluating its potential to treat various forms of cancer.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genta is currently recruiting patients to the AGENDA Trial, a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, that has recently entered clinical trials as a potential treatment for diseases associated with accelerated bone loss. The Company is also developing Tesetaxel(R), a novel, orally absorbed, semi- synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. Ganite and Genasense are available on a "named-patient" basis in countries outside the United States
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Extends Review of Genasense(R) NDA Appeal in Chronic Lymphocytic Leukemia
2. FDA to Extend Review of Data Quality Submission for Genasense(R) in Melanoma
3. Genasense(R) Data in Patients with Advanced Melanoma to be Featured at 4th International Melanoma Congress
4. Genasense(R) Can be Administered by Brief High-Dose IV Infusion
5. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
6. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
7. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
8. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
9. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
10. DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial
11. Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... June 29, 2015 According to a ... Microwave, Cryoablation, IRE, Ultrasound), Mode of treatment (Surgical, Laparoscopic, Percutaneous), ... Forecasts to 2020", published by MarketsandMarkets, the global Tumor Ablation ... at a CAGR of 11.5% from 2015 to 2020. ... 86 F igures spread through 330 ...
(Date:6/29/2015)... Md. , June 29, 2015 The ... New Jersey Board of Professional ... a provider of courses to professional engineers for continuing ... accreditation further demonstrates the value and quality of PDA,s ... . "Our lecture courses and hands-on professional training at ...
(Date:6/29/2015)... 29, 2015  VisionCare Ophthalmic Technologies, Inc. ... devices for the treatment of age-related macular ... "Long-Term (60-month) Results for the Implantable Miniature ... Age in Patients with End-Stage Age-Related Macular ... 5-year data show substantial retention of gains ...
Breaking Medicine Technology:Tumor Ablation Market Worth $515.2 Million by 2020 2Tumor Ablation Market Worth $515.2 Million by 2020 3Tumor Ablation Market Worth $515.2 Million by 2020 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 2Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 3Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 5
... Dec. 21, 2011  In a move aimed at bolstering current ... Hospital Boston have created a new method that combines multiple ... Unlike current approaches, which rely on detecting evidence of drug ... this new method may be able to identify issues years ...
... 2011 Despite the numerous medical advances that happen ... States is still higher than most European countries.  While ... rate of pre-term births, researchers are committed to finding ... Medicine ® researchers are examining a new ...
Cached Medicine Technology:Taking a Predictive Approach to Identifying Adverse Drug Reactions 2Taking a Predictive Approach to Identifying Adverse Drug Reactions 3Northwestern Researchers Trial New Device that May Support Improved Newborn Health 2Northwestern Researchers Trial New Device that May Support Improved Newborn Health 3Northwestern Researchers Trial New Device that May Support Improved Newborn Health 4
(Date:6/29/2015)... ... June 29, 2015 , ... National ... auditor of customer service for the 40-center nursing home group. Sixteen of their ... centers in the United States in one or more customer service areas. Those ...
(Date:6/29/2015)... Newark, Delaware (PRWEB) , ... June 29, 2015 , ... ... Exam Master® announces a partnership with the American Board of Urgent Care Medicine and ... AMA PRA Category 1 Credit™ to Urgent Care physicians and health care professionals. , ...
(Date:6/29/2015)... ... June 29, 2015 , ... OR Manager announced Monday the ... and feel, as well as a redesigned logo and weekly eLetter. The website contains ... now more user-friendly and easier to navigate. , In addition to a refreshed ...
(Date:6/29/2015)... ... June 29, 2015 , ... The Food Safety and ... The Hong Kong Polytechnic University (PolyU) has developed a new method for rapid ... has been a long-term issue in food safety, and becomes particularly important with ...
(Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... ... between personality type and behavior, is a popular focus for corporate training seminars. ... to streamline hiring practices, improve training, foster teamwork, and increase productivity. , ...
Breaking Medicine News(10 mins):Health News:National HealthCare Centers Receive 'Customer Experience Awards' 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 3Health News:National HealthCare Centers Receive 'Customer Experience Awards' 4Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 2Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 3Health News:OR Manager Launches New Website 2Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2Health News:As Demand for DISC Trainers Rises, PeopleKeys Offers Support with “THE DISC FACTOR—Train the Trainer” Webinar 2
... to Digital Converters, with Integrated Signal Compression, Received ... 2008; Samplify,s Prism(TM) Lossless Data Compression Technology Named ... Jan 21 Samplify Systems, Inc., a provider ... is pleased to announce it has received top ...
... Global Marketing Will Oversee Life Sciences Software Group , ... ... Group LTD ("KineMatik"), providers of software solutions for managing scientific ... Michael G. Jarjour as President & CEO., , ,Mr. Jarjour, ...
... one of the industry,s most respected suppliers of adult diapers, walkers, ... a name for itself online as the leader in Customer Service ... ... Greenville, SC (PRWEB) January 21, 2009 -- Homecare is the fastest ...
... Children,s Health Journal has just come out. In it,s 23rd year it ... and developmental progress. It is both a keepsake, and a lifesaver in ... since its inception. A diaper bag must. , ... Fountain Valley, CA ...
... 20 Nationwide Health Properties, Inc. (NYSE: NHP ) announced the tax treatment for its ... 2008:, COMMON STOCK (CUSIP# 638620104), 2008 ... Taxable Return Total Unrecaptured, Record ... Capital Section, Date ...
... South Africa,s new Children,s Act came into effect, granting ... relating to reproductive health, including the right to access ... decide whether or not to give out condomspolicies that ... , say could damage the health of the country,s ...
Cached Medicine News:Health News:Samplify Systems Receives Top Honors From Electronic Products and EDN Magazines 2Health News:Samplify Systems Receives Top Honors From Electronic Products and EDN Magazines 3Health News:KineMatik Group Ltd. Appoints Michael G. Jarjour as President & CEO 2Health News:KineMatik Group Ltd. Appoints Michael G. Jarjour as President & CEO 3Health News:Home Delivery Medical Transforms Customer Service On the Web for Seniors and Homecare Providers 2Health News:Home Delivery Medical Transforms Customer Service On the Web for Seniors and Homecare Providers 3Health News:Pocket Reference Journals Releases Latest Edition of "All About Me" Leading Children's Immunization Journal for New Moms 2Health News:Pocket Reference Journals Releases Latest Edition of "All About Me" Leading Children's Immunization Journal for New Moms 3Health News:NHP Announces Tax Treatment of 2008 Distributions 2Health News:NHP Announces Tax Treatment of 2008 Distributions 3Health News:South African policy on adolescents' rights to access condoms is causing confusion 2
... by seeing more patients per day. Utilizing the ... a 14-18 patients per day practice into a ... test sequences, youll perform accurate refractions in less ... making it easy to delegate tasks to office ...
... web-based application for secure access to ... reporting system. It is highly user ... comprehensive analysis, and professional reporting from ... with HIPAA requirements, reports also include ...
... Nothing can be more frustrating to a ... section of tissue than using instruments that are ... simple, or more complex, we offer a wide ... From realigning and polishing the tips to standard ...
... We repair most Olympus fiber and ... and intubation scopes used in OR and ... all repairs meet or exceed the standards ... with a 120-day warranty against defects in ...
Medicine Products: